These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25313427)

  • 1. Financial stability in biobanking: unique challenges for disease-focused foundations and patient advocacy organizations.
    Bromley RL
    Biopreserv Biobank; 2014 Oct; 12(5):294-9. PubMed ID: 25313427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the Challenge of Financial Sustainability in Biobanking.
    Campos AH; Schreeder M; Parry-Jones A; Abdelhafiz AS; Larson D; Pruetz B; Geddes T; Salman A; Lazaris A
    Biopreserv Biobank; 2015 Dec; 13(6):387-95. PubMed ID: 26697907
    [No Abstract]   [Full Text] [Related]  

  • 6. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era.
    Chalmers D; Nicol D; Kaye J; Bell J; Campbell AV; Ho CW; Kato K; Minari J; Ho CH; Mitchell C; Molnár-Gábor F; Otlowski M; Thiel D; Fullerton SM; Whitton T
    BMC Med Ethics; 2016 Jul; 17(1):39. PubMed ID: 27405974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustainability in biobanking.
    Simeon-Dubach D; Henderson MK
    Biopreserv Biobank; 2014 Oct; 12(5):287-91. PubMed ID: 25314050
    [No Abstract]   [Full Text] [Related]  

  • 8. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Cooperation Between Academic Biobanks and Biomedical Industry: Better Mutual Understanding and New Collaborative Models Are Needed.
    Simeon-Dubach D; Roehrl MH; Hofman P; Puchois P
    Biopreserv Biobank; 2020 Apr; 18(2):144-149. PubMed ID: 32043910
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BBMRI-ERIC: the novel gateway to biobanks. From humans to humans.
    Mayrhofer MT; Holub P; Wutte A; Litton JE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):379-84. PubMed ID: 26860601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Biobanks Are Assessing and Measuring Their Financial Sustainability.
    Brown T; Kelly DD; Vercauteren SM; Wilson WH; Werner A
    Biopreserv Biobank; 2017 Feb; 15(1):65-71. PubMed ID: 27869475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From AAA+ to BB- and on the way back again.
    Riegman PH
    Biopreserv Biobank; 2014 Oct; 12(5):292-3. PubMed ID: 25314224
    [No Abstract]   [Full Text] [Related]  

  • 18. Banking on the future of stem cells. Leszek Borysiewicz, head of the UK Medical Research Council (MRC), interviewed by Monya Baker.
    Borysiewicz L
    Nature; 2008 Mar; 452(7185):263. PubMed ID: 18354439
    [No Abstract]   [Full Text] [Related]  

  • 19. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organization of BBMRI.pl: The Polish Biobanking Network.
    Witoń M; Strapagiel D; Gleńska-Olender J; Chróścicka A; Ferdyn K; Skokowski J; Kalinowski L; Pawlikowski J; Marciniak B; Pasterk M; Matera-Witkiewicz A; Kozera Ł
    Biopreserv Biobank; 2017 Jun; 15(3):264-269. PubMed ID: 28103080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.